Literature DB >> 16236366

Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.

Su-Kil Seo1, Hyoun-Mi Seo, Hye-Young Jeong, Il-Whan Choi, Yeong-Min Park, Hideo Yagita, Lipieng Chen, In-Hak Choi.   

Abstract

B7-H1 and B7-DC expressed on antigen-presenting cells inhibit the T-cell response via the PD-1 counter-receptor on T cells, and co-stimulate T-cell immunity under certain conditions via an unidentified co-stimulatory receptor. However, little is known about the functional consequence of T-cell-associated B7-H1 or B7-DC in the T-cell immune response. Therefore, we evaluated the physiological role of B7-H1 and B7-DC expressed on T cells in terms of cell proliferation and cytokine production by alloreactive T cells. We found that PD-1, B7-H1, and B7-DC were up-regulated in alloreactive CD4(+) and CD8(+) T cells in vitro and in vivo. In the alloreactive T-T model, blockade of the B7-H1:PD-1 or B7-DC:PD-1 pathways significantly increased the proliferation, and IFN-gamma and IL-2 production of alloreactive T cells, although it did not affect the production of other cytokines, including IL-4, IL-10, and IL-12. The data indicate that T-cell-associated B7-H1 and B7-DC negatively regulate the T-cell response via the T-T interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236366     DOI: 10.1016/j.imlet.2005.09.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  17 in total

1.  Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer.

Authors:  S Muenst; A R Schaerli; F Gao; S Däster; E Trella; R A Droeser; M G Muraro; P Zajac; R Zanetti; W E Gillanders; W P Weber; S D Soysal
Journal:  Breast Cancer Res Treat       Date:  2014-05-20       Impact factor: 4.872

Review 2.  Role of the tumor microenvironment in mature B-cell lymphoid malignancies.

Authors:  Nathan H Fowler; Chan Yoon Cheah; Randy D Gascoyne; John Gribben; Sattva S Neelapu; Paolo Ghia; Catherine Bollard; Stephen Ansell; Michael Curran; Wyndham H Wilson; Susan O'Brien; Cliona Grant; Richard Little; Thorsten Zenz; Loretta J Nastoupil; Kieron Dunleavy
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

3.  Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells.

Authors:  Junfang Deng; Yigang Qian; Lei Geng; Haiyang Xie; Yan Wang; Guoping Jiang; Lin Zhou; Ming Zhang; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-02       Impact factor: 4.553

4.  Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms.

Authors:  Mikayel Mkrtichyan; Yana G Najjar; Estella C Raulfs; Maher Y Abdalla; Raed Samara; Rinat Rotem-Yehudar; Larry Cook; Samir N Khleif
Journal:  Eur J Immunol       Date:  2011-08-17       Impact factor: 5.532

5.  B7-h1 expressed by activated CD8 T cells is essential for their survival.

Authors:  Vesna Pulko; Kimberley J Harris; Xin Liu; Rachel M Gibbons; Susan M Harrington; Christopher J Krco; Eugene D Kwon; Haidong Dong
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

6.  Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B.

Authors:  Ji Chen; Xiao-Mei Wang; Xue-Jie Wu; Yan Wang; Hong Zhao; Bing Shen; Gui-Qiang Wang
Journal:  Inflamm Res       Date:  2010-07-27       Impact factor: 4.575

7.  The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

Authors:  Hazem Ghebeh; Shamayel Mohammed; Abeer Al-Omair; Amal Qattan; Cynthia Lehe; Ghofran Al-Qudaihi; Naser Elkum; Mohamed Alshabanah; Suad Bin Amer; Asma Tulbah; Dahish Ajarim; Taher Al-Tweigeri; Said Dermime
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

8.  Hepatoma cells up-regulate expression of programmed cell death-1 on T cells.

Authors:  Ji Chen; Xue-Jie Wu; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

9.  B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets.

Authors:  Mikayel Mkrtichyan; Yana G Najjar; Estella C Raulfs; Linda Liu; Solomon Langerman; Geoffrey Guittard; Laurent Ozbun; Samir N Khleif
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

Review 10.  Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies.

Authors:  Jonathan Moreira; Alexander Tobias; Michael P O'Brien; Mark Agulnik
Journal:  Drugs       Date:  2017-05       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.